Phibro Historical Income Statement

PAHC Stock

USD 23.37 0.22 0.93%

Historical analysis of Phibro Animal income statement accounts such as Gross Profit of 196.2 M, Other Operating Expenses of 630.9 M, Operating Income of 51.9 M or Ebit of 35.5 M can show how well Phibro Animal Health performed in making a profits. Evaluating Phibro Animal income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Phibro Animal's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Phibro Animal Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Phibro Animal Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Phibro Income Statement Analysis

Phibro Animal Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Phibro Animal shareholders. The income statement also shows Phibro investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Phibro Animal Income Statement Chart

At present, Phibro Animal's Research Development is projected to increase significantly based on the last few years of reporting. The current year's Net Income Applicable To Common Shares is expected to grow to about 42.5 M, whereas Interest Expense is forecasted to decline to about 18.1 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Net Income

Total Revenue

Total revenue comprises all receipts Phibro Animal Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Phibro Animal Health minus its cost of goods sold. It is profit before Phibro Animal operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Phibro Animal Health. It is also known as Phibro Animal overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Phibro Animal Health financial statement analysis. It represents the amount of money remaining after all of Phibro Animal Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Phibro Animal's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Phibro Animal Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2022	2023	2024 (projected)
Interest Expense	17.9M	22.0M	18.1M
Depreciation And Amortization	34.0M	36.2M	38.0M

Interest Expense Depreciation And Amortization

Phibro Animal income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		-0.39	0.82	0.78	0.77	0.8	0.06	0.27	0.92	0.39	0.77	0.82	0.18	-0.43	0.04	0.49	0.19	0.64	-0.12	-0.77	0.12	0.88	0.84
Interest Expense	-0.39		-0.29	-0.23	-0.37	-0.19	-0.12	-0.26	-0.21	-0.31	-0.15	-0.28	-0.71	-0.3	-0.6	-0.58	-0.69	-0.78	0.01	0.64	-0.52	-0.26	-0.4
Selling General Administrative	0.82	-0.29		0.96	0.95	0.98	0.19	0.44	0.73	0.6	0.95	1.0	0.29	-0.27	0.16	0.48	0.29	0.61	-0.03	-0.6	0.27	0.74	0.71
Total Revenue	0.78	-0.23	0.96		0.98	0.99	0.36	0.61	0.68	0.74	0.99	0.97	0.39	-0.2	0.27	0.5	0.38	0.64	0.0	-0.59	0.31	0.63	0.6
Gross Profit	0.77	-0.37	0.95	0.98		0.95	0.44	0.66	0.6	0.78	0.94	0.95	0.53	-0.1	0.41	0.54	0.53	0.74	-0.03	-0.64	0.4	0.56	0.56
Other Operating Expenses	0.8	-0.19	0.98	0.99	0.95		0.27	0.54	0.72	0.68	1.0	0.98	0.31	-0.26	0.18	0.47	0.29	0.59	0.0	-0.57	0.26	0.69	0.65
Operating Income	0.06	-0.12	0.19	0.36	0.44	0.27		0.78	-0.07	0.71	0.31	0.19	0.61	0.15	0.62	0.19	0.64	0.42	-0.13	-0.07	0.13	-0.33	-0.34
Ebit	0.27	-0.26	0.44	0.61	0.66	0.54	0.78		0.11	0.98	0.57	0.44	0.75	0.16	0.69	0.46	0.7	0.57	0.15	-0.39	0.43	-0.04	-0.06
Research Development	0.92	-0.21	0.73	0.68	0.6	0.72	-0.07	0.11		0.2	0.7	0.73	-0.09	-0.67	-0.19	0.28	-0.05	0.48	-0.23	-0.54	-0.19	0.92	0.8
Ebitda	0.39	-0.31	0.6	0.74	0.78	0.68	0.71	0.98	0.2		0.7	0.6	0.76	0.14	0.67	0.52	0.7	0.63	0.16	-0.48	0.49	0.1	0.09
Cost Of Revenue	0.77	-0.15	0.95	0.99	0.94	1.0	0.31	0.57	0.7	0.7		0.95	0.31	-0.26	0.18	0.46	0.29	0.57	0.01	-0.55	0.25	0.65	0.61
Total Operating Expenses	0.82	-0.28	1.0	0.97	0.95	0.98	0.19	0.44	0.73	0.6	0.95		0.29	-0.27	0.16	0.47	0.29	0.61	-0.03	-0.6	0.27	0.74	0.71
Income Before Tax	0.18	-0.71	0.29	0.39	0.53	0.31	0.61	0.75	-0.09	0.76	0.31	0.29		0.6	0.95	0.5	0.97	0.78	0.05	-0.47	0.7	-0.14	0.02
Total Other Income Expense Net	-0.43	-0.3	-0.27	-0.2	-0.1	-0.26	0.15	0.16	-0.67	0.14	-0.26	-0.27	0.6		0.63	0.12	0.53	0.15	0.22	0.02	0.63	-0.55	-0.28
Net Income	0.04	-0.6	0.16	0.27	0.41	0.18	0.62	0.69	-0.19	0.67	0.18	0.16	0.95	0.63		0.22	0.97	0.71	-0.17	-0.29	0.58	-0.27	-0.12
Income Tax Expense	0.49	-0.58	0.48	0.5	0.54	0.47	0.19	0.46	0.28	0.52	0.46	0.47	0.5	0.12	0.22		0.36	0.48	0.62	-0.7	0.6	0.36	0.43
Net Income From Continuing Ops	0.19	-0.69	0.29	0.38	0.53	0.29	0.64	0.7	-0.05	0.7	0.29	0.29	0.97	0.53	0.97	0.36		0.82	-0.19	-0.39	0.58	-0.15	0.0
Non Operating Income Net Other	0.64	-0.78	0.61	0.64	0.74	0.59	0.42	0.57	0.48	0.63	0.57	0.61	0.78	0.15	0.71	0.48	0.82		-0.28	-0.6	0.38	0.4	0.46
Tax Provision	-0.12	0.01	-0.03	0.0	-0.03	0.0	-0.13	0.15	-0.23	0.16	0.01	-0.03	0.05	0.22	-0.17	0.62	-0.19	-0.28		-0.23	0.48	-0.04	0.01
Interest Income	-0.77	0.64	-0.6	-0.59	-0.64	-0.57	-0.07	-0.39	-0.54	-0.48	-0.55	-0.6	-0.47	0.02	-0.29	-0.7	-0.39	-0.6	-0.23		-0.61	-0.59	-0.71
Net Interest Income	0.12	-0.52	0.27	0.31	0.4	0.26	0.13	0.43	-0.19	0.49	0.25	0.27	0.7	0.63	0.58	0.6	0.58	0.38	0.48	-0.61		-0.05	0.22
Reconciled Depreciation	0.88	-0.26	0.74	0.63	0.56	0.69	-0.33	-0.04	0.92	0.1	0.65	0.74	-0.14	-0.55	-0.27	0.36	-0.15	0.4	-0.04	-0.59	-0.05		0.89
Extraordinary Items	0.84	-0.4	0.71	0.6	0.56	0.65	-0.34	-0.06	0.8	0.09	0.61	0.71	0.02	-0.28	-0.12	0.43	0.0	0.46	0.01	-0.71	0.22	0.89

Click cells to compare fundamentals

Phibro Animal Account Relationship Matchups

Phibro Animal income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	32.3M	31.9M	32.7M	34.0M	36.2M	38.0M
Interest Expense	11.9M	11.8M	12.9M	17.9M	22.0M	18.1M
Selling General Administrative	187.7M	196.5M	206.4M	226.4M	259.8M	139.2M
Total Revenue	800.4M	833.4M	942.3M	977.9M	1.0B	687.4M
Gross Profit	256.9M	271.4M	285.4M	298.2M	313.1M	196.2M
Other Operating Expenses	731.2M	758.5M	863.3M	906.0M	964.4M	630.9M
Operating Income	36.9M	43.0M	46.3M	71.8M	53.3M	51.9M
Ebit	36.9M	73.6M	82.1M	82.6M	48.4M	35.5M
Research Development	13.7M	17.8M	20.8M	24.4M	29.2M	30.7M
Ebitda	69.2M	105.5M	114.8M	116.6M	84.6M	48.0M
Cost Of Revenue	543.5M	562M	656.9M	679.7M	704.6M	491.2M
Total Operating Expenses	187.7M	196.5M	206.4M	226.4M	260.3M	139.7M
Income Before Tax	55.5M	66.5M	72.3M	54.1M	10.9M	10.4M
Total Other Income Expense Net	18.6M	(8.4M)	(6.7M)	(17.8M)	(42.4M)	(40.3M)
Net Income Applicable To Common Shares	33.6M	54.4M	49.2M	32.6M	37.5M	42.5M
Net Income	33.6M	54.4M	49.2M	32.6M	2.4M	2.3M
Income Tax Expense	16.8M	22M	12.1M	21.5M	8.5M	9.8M
Net Income From Continuing Ops	33.6M	54.4M	49.2M	32.6M	2.4M	2.3M
Non Operating Income Net Other	(826K)	4.5M	5.2M	(2.5M)	(2.8M)	(2.7M)
Tax Provision	22.0M	12.1M	23.2M	21.5M	8.5M	8.1M
Interest Income	1.8M	838K	816K	3.4M	4.5M	2.8M
Net Interest Income	(12.9M)	(12.9M)	(11.9M)	(15.3M)	(18.5M)	(19.5M)
Reconciled Depreciation	32.3M	31.9M	32.7M	34.0M	36.2M	34.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.94)

Dividend Share

0.48

Earnings Share

0.43

Revenue Per Share

25.843

Quarterly Revenue Growth

0.126

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Historical Income Statement

About Phibro Income Statement Analysis

Phibro Animal Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Net Income

Phibro Animal income statement Correlations

Phibro Animal Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Phibro Animal income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Other Operating Expenses
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Other Operating Expenses	+ 0.98	Selling General Administrative
Gross Profit	+ 0.98	Total Revenue

Non Operating Income Net Other	- 0.78	Interest Expense
Interest Income	- 0.77	Depreciation And Amortization
Extraordinary Items	- 0.71	Interest Income
Income Before Tax	- 0.71	Interest Expense
Interest Income	- 0.7	Income Tax Expense
Net Income From Continuing Ops	- 0.69	Interest Expense